otenabant
Sign in to saveAlso known as CP-945,598, CP-945598
Otenabant (CP-945,598) is a drug that acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer for the treatment of obesity, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Otenabant (CP-945,598) is a drug that acts as a potent and highly selective CB1 antagonist. It was developed by Pfizer for the treatment of obesity, but development for this application has been discontinued following the problems seen during clinical use of the similar drug rimonabant.
==See also== Cannabinoid receptor antagonist
Excerpted from Wikipedia’s “otenabant” article, available under the CC BY-SA 4.0 licence.